The Physician Payments Sunshine Act, introduced by Sens. Chuck Grassley and Herb Kohl, seeks to relieve some of that burden by requiring all payments more than $100 made by a drug or medical device company to a doctor be reported.
Doctors justify the “pharmaceutical pay-off” saying that the "doctor/industry partnership" is often needed to help develop beneficial new drugs.
But, the “doctor/industry partnership" is circular reasoning. Here’s the effect: Doctors argue that, with the help of doctors, the pharmaceutical companies develop so-called "new drugs," which the doctors then prescribes to patients, who then pay "big bucks" for the "new-drugs," so that the pharmaceutical company can make "big bucks" to “pay-off” the doctors.
It appears that the “MDs” are peddling “BS.” See, Ibby Caputo, The Washington Post 08/18/2009 Read Article: The Washington Post